Introduction
Mesenchymal stem cells (MSCs) are rare cells of nonhematopoietic stromal origin, residing in the bone marrow (BM) [1] and a great variety of other tissues [2] , which are able to differentiate into cells of the mesodermal lineage, including osteoblasts, adipocytes and chondrocytes [3] . This makes them an attractive cell source for the development of novel cell-based therapies that are usually referred to as cell transplantation and regenerative medicine [4, 5] . Besides their potential use in tissue repair and regeneration, MSCs have recently been discovered to possess immunomodulatory properties whereby they exert a profound inhibitory impact on T cell proliferation in vitro and in vivo. In vitro, studies carried out using human or mouse MSCs indicate that these cells act in a dose-dependent fashion to strongly suppress T lymphocyte proliferation triggered by cellular stimuli, non-specific mitogenic stimuli or antigen [6] [7] [8] . In vivo, MSCs may improve the result of allogeneic transplantation by promoting hematopoietic engraftment and limiting graft-versus-host diseases (GVHD), as well as ameliorating autoimmune diseases such as experimental autoimmune encephalitis (EAE) and collagen-induced arthritis (CIA) [7, [9] [10] [11] [12] . Although the immunosuppressive properties of MSCs have been well established [13, 14] , the mechanisms are still largely obscure. Soluble factors such as hepatocyte growth factor (HGF), transforming growth factor (TGF-β) [15, 16] , indoleamine 2,3-dioxygenase (IDO) [17] , interleukin-10 (IL-10) [18] and unidentified factors [15, 16, 19] as well as contact-dependent mechanisms [20, 21] have been implicated.
Interferon gamma (IFNγ) is a major proinflammatory cytokine secreted by activated T and NK cells [22] . can strongly up-regulate immune-related genes including major histocompatibility complex (MHC) [19, 23] and co-stimulatory molecules CD80 and CD86 [22, 24] . Recently, English et al. [25] reported that IFNγ produced by activated T cells is required for murine MSCs to exert their immunosuppression function, and the effect of mMSCs appears to be mediated by a soluble factor IDO secreted from these stem cells. B7-H1, also called PD-L1 (programmed death legend 1), is found in various tissues and acts as an inhibitory co-stimulatory molecule during immune responses [26] . A recent study by Augello et al. [27] showed that Ab-mediated neutralization of B7-H1 on MSCs led to diminished ability of immunosuppression. However, the potential inter-relationship between IFNγ and B7-H1 in the T-MSC interplay during MSC-mediated immunosuppression has not been examined. In this study, we found that higher concentrations of IFNγ were present in the supernatant of the MSC/activated T co-culture system. This was accompanied by up-regulation of B7-H1 on the surface of MSCs and significant suppression of T lymphocyte proliferation. Co-culturing of MSCs with T lymphocytes derived from IFNγ-/-mice dramatically reduced their ability to suppress T lymphocyte proliferation, and, interestingly, did not lead to B7-H1 upregulation. Supplement of exogenous IFNγ restored B7-H1 up-regulation and inhibition of lymphocyte proliferation. Finally, we found that knockdown of B7-H1 in MSCs abolished their ability to inhibit T cell proliferation. Our results suggest that the cytokine IFNγ triggers the immunosuppression function of MSCs via up-regulation of B7-H1 expression. These findings may have implications in designing immune intervention strategies for amelioration of autoimmune disease symptoms [28, 29] and for eliciting anti-rejection response in transplantation [30] and regenerative medicine [19] .
Results

Characterization of murine bone-marrow-derived MSCs: multipotent differentiation and immunosuppressive effect
MSCs were derived from C57BL/6J mouse BM according to an established protocol [31] . These cells exhibited spindle-shaped morphology and continuous proliferation. MSCs from the 8th passage were analyzed for expression of cell surface molecules by flow cytometry. As reported in other studies, these cells were found to express c-kit, Sca-1 and SSEA-1, and they were negative for FLK-1, Thy1.1 and MHC-II ( Figure 1A ). These cells did express MHC class I (K b and D b ) but were negative for CD11b, CD31 and CD34 (data not shown). To further characterize the derived MSCs, we examined their capacity of multilineage differentiation into adipocytes, osteoblasts and chondrocytes, and our results showed that they could differentiate into all three cell types under appropriate conditions ( Figure 1B) . These results indicated the successful culture of MSCs, and MSCs at the 8th passage were used for all subsequent functional assays in this study.
To examine their inhibitory effect on T lymphocyte proliferation, MSCs were added at various ratios to freshly isolated lymphocytes (responser, R) stimulated with irradiated allogenic cells (stimulator, S) (called mixed lymphocyte cultures, MLR), (Figure 1C-1) or freshly isolated lymphocytes (responser, R) activated with 3 mg/ml mitogen ConA ( Figure 1C-2) or freshly isolated lymphocytes (responser, R) stimulated with 100 ng/ml of anti-CD3 plus 200 ng/ml anti-CD28 (TCR stimulation pathway, labeled with sti) (Figure 1C-3) . T cell proliferation was measured using [ 3 H]-thymidine incorporation. The results showed that proliferation was strongly inhibited by MSCs in all of the above assays in an MSCs cell-number-dependent manner (data not shown), which is consistent with previous reports.
High level of IFNγ in the supernatant of stimulated lymphocytes co-cultured with MSCs
Because some previous reports have shown that IL-10 and TGF-β are involved in the immunosuppression response mediated by MSCs, we first examined the cytokine profile in the supernatant collected from co-cultured lymphocytes and MSCs using ELISA. The results showed that IL-10 or TGF-β was not detectable (Figure 2A ), suggesting that under our co-culture conditions IL-10 and TGF-β are not involved in the proliferation inhibition mediated by MSCs. We also examined the concentrations of IL-12 and TNF-α, two cytokines known to enhance immune responses. The results showed that TNF-α but not IL-12 was detected. IFNγ has been implicated by a previous study to be important for MSC-mediated immunosuppression [22, 25] ; we thus examined its level in our co-culture system which consisted of stimulated splenocytes (SP) in the presence of MSCs, and found that IFNγ was present at a high level in the culture supernatant (more than 750 pg/ml) ( Figure  2A ). The concentration of IFNγ was not affected by the presence (MSC + SP) or absence of MSCs (Figure 2A ), suggesting that it was produced by the stimulated lymphocytes. Intracellular staining showed that both the CD4+ T and CD8+ T cells produced IFNγ from the beginning of their stimulation ( Figure 2B ). This suggested that IFNγ was produced by SP and there was more IFNγ production from CD8+ T cells ( Figure 2B -lower) than from CD4+ T cells ( Figure 2B-upper) . This indicated that CD8+ T cells were the dominant IFNγ-producing population and this result is consistent with Krampera et al. [22] .
IFNγ up-regulates B7-H1 expression on MSCs
A previous study showed that IFNγ induced B7-H1 ex- pression in murine MSCs but the up-regulation of B7-H1 was not involved in immunosuppresion [25] . Conversely, Augello et al. showed that Ab-mediated neutralization of B7-H1 on murine MSCs diminished immunosuppression.
To clarify the potential role of B7-H1, we were interested in investigating whether B7-H1 expression was induced by IFNγ in our co-culture system, and, if so, whether the expression of B7-H1 could mediate the immunosuppressive effect of MSCs. The expression of B7-H1 was examined using real-time PCR and flow cytometry. The results showed that naïve MSCs did not express significant levels of B7-H1; however, when MSCs were co-cultured with stimulated lymphocytes, both mRNA and protein levels of B7-H1 increased significantly (P = 0.0158 and P = 0.0001, respectively) ( Figure 3A-1, 2 ). This result indicated that activated lymphocytes up-regulated B7-H1 expression on MSCs. The supernatant collected from the co-culture had a similar ability to stimulate B7-H1 expression in MSCs ( Figure  3B ), suggesting that cytokine(s) in the supernatant might be responsible for inducing B7-H1 expression. To probe which cytokine was responsible for B7-H1 up-regulation, we performed Ab-mediated neutralization experiments, and the results showed that only the specific Ab against IFNγ was able to abolish the induction of B7-H1 expression Figure 3B ). To further confirm the role of IFNγ, individual cytokines were added to naive MSCs; as expected, only IFNγ could stimulate B7-H1 expression ( Figure 3C ). We also examined the expression of other members of the B7 family, B7-H2, B7-H3 and B7-H4, and found that they were not up-regulated by IFNγ ( Figure 3D ). To further explore the time course of B7-H1 expression induced by IFNγ, we added exogenous IFNγ into the culture of naïve MSCs and analyzed B7-H1 expression pattern. The results showed that within the dose range from 0.05 to 5 ng/ml IFNγ could induce B7-H1 expression in a dose-dependent manner ( Figure 3E-1) . Moreover, B7-H1 expression increased to a maximum within 24 h after IFNγ treatment, and the level lasted for at least 120 h ( Figure  3E -2). Thus, the expression of B7-H1 was rapidly induced in MSCs in response to IFNγ.
Activated lymphocytes derived from IFNγ -/-mouse did not induce B7-H1 expression and failed to trigger immunosuppression function of MSCs
To investigate whether IFNγ signaling plays an important role in triggering the immunosuppression function of MSCs, and the potential role of B7-H1 induction by IFNγ, we used lymphocytes derived from IFNγ knock- npg out mice (IFNγ-/-) in the co-culture with wild-type (wt) MSCs. Interestingly, co-culture with activated IFNγ-/-T lymphocytes failed to up-regulate B7-H1 expression in MSCs ( Figure 4A ). Meanwhile, proliferation of stimulated lymphocytes derived from IFNγ-/-mice increased significantly compared with that of wt lymphocytes under similar co-culture conditions ( Figure 4B ) (P < 0.0001). Thus, IFNγ-/-lymphocytes failed to induce B7-H1 expression in MSCs and were unable to efficiently trigger the immunosuppression function of these cells.
To confirm the critical role of IFNγ in inducing B7-H1 expression and in triggering MSC-mediated immunosuppression, exogenous IFNγ was added into the co-culture of MSCs with IFNγ-/-lymphocytes; B7-H1 expression and immunosuppresion capacity of MSCs were then examined. The results showed that exogenous IFNγ could rescue B7-H1 expression (data not shown) and restore the ability of the MSCs to inhibit lymphocyte proliferation ( Figure 4C ). Taken together, our results indicate that IFNγ plays a critical role in triggering MSC-mediated immunosuppression, 
Knockdown of B7-H1 in MSCs abolished their immunosuppression function
To obtain direct evidence that B7-H1 induction by
IFNγ is critical in MSC-mediated inhibition of T cell proliferation, we used B7-H1 specific siRNA to knockdown its expression. Among the four synthesized siRNAs, one was found to effectively reduce B7-H1 expression (termed MSCs-B7-H1-) while the negative control (termed MSCs- npg B7-H1+) had no effect on the B7-H1 expression in MSCs as shown by real-time PCR (P = 0.001) ( Figure 5A-1 ). This effect was confirmed at protein level by flow cytometry analysis (P = 0.0002) ( Figure 5A-2) . In the co-culture with stimulated lymphocytes, the B7-H1 knockdown MSCs exhibited a significantly reduced ability to inhibit lymphocyte proliferation (P = 0.0102) ( Figure 5B ). Cell division assay showed that both CD4+ T cells and CD8+ T cells were inhibited using CSFE tracer ( Figure 5C ). These results suggested that B7-H1 expression is important for MSC-mediated immunosuppression. As B7-H1 is one of the inhibitory co-stimulators expressed on cell surface which functions via interaction with its receptor PD-1 on T or B cells [26] , cell-cell contact is necessary for B7-H1-mediated immunosuppression. Interestingly, PD-1 expression was increased in activated T lymphocytes (data not shown), regardless of whether MSCs were present or not. To determine whether cell-cell contact is needed in the inhibition mediated by MSCs, trans-membranes were used to separate stimulated lymphocytes (added in the upper chamber) and MSCs (cultured in the lower chamber). The results showed that the proliferation of lymphocytes separated from MSCs by the transmembrane was significantly higher than that of co-cultured cells without the transmembrane (P = 0.0001) (Figure 5D-1) . Cell division assay further suggested that the transmembrane blocked MSC-mediated inhition ( Figure  5D-2) . Thus, cell-cell contact is required for MSC-mediated inhibition of lymphocyte proliferation under our experimental conditions.
Immunosuppression by MSCs does not involve Tregs
There have been conflicting reports on the potential involvement of regulatory T cells (Tregs) in MSC-mediated immunosuppresion [32] [33] [34] . To clarify whether Tregs play any role in the inhibition of lymphocyte proliferation in our co-culture system, we examined the Treg population and found that the percent of CD4+CD25+FoxP3+ cells was maintained at a similar level in lymphocytes co-cultured with or without MSCs ( Figure 6A and 6B ). In addition, cytokines secreted by Tregs (such as IL-10 and TGF-β) are not detected in our system (Figure 2A) . Thus, our result suggests that immunosuppression by MSCs observed in our experiments is not mediated by Tregs.
Discussion
IFNγ is a major proinflammatory cytokine secreted by activated T and NK cells [22] , and can strongly up-regulate many immune-related genes including MHC [19, 23] and co-stimulatory molecules [22, 24] . Recently, IFNγ was shown to be a double-edged sword in immune response because it can induce Tregs that further inhibit immune response by release of inhibitory cytokines (such as IL-10 and TGF-β) or by cell-cell contact [35] . More recently, English et al. reported that IFNγ produced by activated T cells is required for murine MSCs to exert their immunesuppression function, and the effect of mMSCs appears to be mediated by a soluble factor IDO secreted from these stem cells [25] .
B7-H1 was initially reported mainly as a co-inhibitor molecule by Chen's group and now has been identified on resting T cells, B cells, DCs and macrophages, where it is further up-regulated upon activation [26, 36] . Other groups also reported that B7-H1 is present on endothelial cells and cells from other non-lymphoid organs [36] [37] [38] [39] . The exact immune functions of B7-H1 are not fully understood. With respect to immunosuppression mediated by MSCs, Augello et al. first reported that murine MSCs inhibit lymphocyte proliferation by activation of the B7-H1-mediated signaling pathway. They found that MSCs inhibited the activation and proliferation of murine lymphocytes via engagement of the inhibitory molecule B7-H1 to its cognate receptor on target immune cells, and MSC-mediated inhibition could be blocked by anti-B7-H1 antibody [27] . Intriguingly, Stagg et al. [23] found that IFNγ induced B7-H1 expression in human MSCs but B7-H1 up-regulation was not involved in immunosuppression by human MSCs. Thus, the inter-relationship between IFNγ and B7-H1 in the MSC-lymphocyte interplay merits further investigation.
In this report, we analyzed the pattern of cytokines in the supernatant of stimulated lymphocytes co-cultured with MSCs, and found that IL-10, IL-12 and TGF-β were not detectable but both IFNγ and TNFα were present at high levels. Co-culture with stimulated lymphocytes significantly up-regulated B7-H1 expression on MSCs, an effect which can be mimicked by supernatants from the co-culture. Further analyses indicated that IFNγ present in the co-culture supernatant was primarily responsible for the induction of B7-H1 expression on MSCs. To investigate whether IFNγ signaling plays an important role in triggering the immunosuppression function of MSCs, and to probe the potential role of B7-H1 induction by IFNγ, we performed similar co-culture experiments using lymphocytes derived from IFNγ-/-knockout mice. Our results indicated that IFNγ produced by lymphocytes plays a critical role in triggering immunosuppression by MSCs, likely through induction of B7-H1 expression. Consistent with this notion, supplement of exogenous IFNγ into the co-culture of activated IFNγ-/-lymphocytes with wt MSCs restored both B7-H1 induction and MSC-mediated immunosuppression. In support of an important role of B7-H1, knockdown of B7-H1 expression on MSCs by RNAi significantly attenuated the immunosuppression function of MSCs.
Both cell-cell contact and soluble factors have been implicated in MSC-mediated immunosuppression, and different experimental settings often led to different results [33, 40] . In our study, we found that priming of MSCs by lymphocyte-derived IFNγ led to up-regulation of B7-H1 on MSCs, which appeared to be critical for mediating the immunosuppression function of these cells. B7-H1 is known to function by interaction with its cognate receptor on target cells, a process mediated by cell-cell contact. Consistent with this notion, our co-culture experiments using transmembranes to separate lymphocytes and MSCs showed that inhibition of lymphocyte proliferation was largely abolished without direct contact with MSCs.
Recent reports showed that IFNγ is a key factor to induce CD4+CD25+ Tregs [41, 42] . While some reports showed that induced Tregs were involved in the proliferation inhibition mediated by MSCs [32, 34] , other studies showed the opposite results [33] . Immunosuppression by MSCs observed in our experiments does not appear to be mediated by Tregs.
MSCs, due to their immunomodulation property, may have wide applications in clinical settings, such as amelioration of autoimmune diseases, reducing rejection response in transplantation and in regenerative medicine. In this study, we revealed a new interplay between MSCs and T cells, whereby activated T cells prime MSCs for immunosuppression through IFNγ signaling and subsequent up-regulation of B7-H1 in MSCs, while primed MSCs in turn suppress T cell proliferation via B7-H1-mediated inhibitory signaling. Whether MSCs mediate immunosuppression in vivo via B7-H1 up-regulation by IFNγ is under investigation.
Materials and Methods
Isolation and culture of murine MSCs
MSCs were generated from C57BL/6J, 6-8-week old, female mice (Shanghai Laboratory Animal Center, Chinese Academy of Sciences). Mice were sacrificed by cervical dislocation; femurs and tibiae were removed and cleaned of all connective tissue. BM cells were collected by flushing femurs and tibiae with 1 × phosphatebuffered saline (PBS) buffer using a 26-gauge needle. Material was filtered and washed twice with centrifugation at 1 500 rpm for 5 min in 1 × PBS/4% FCS medium. To initiate MSC culture, cells were plated in 75-cm 2 dishes (BD Biosciences) at a concentration of 5 × 10 5 /ml/cm 2 nucleated cells in Dulbecco modified Eagle medium (DMEM) with low glucose (HyClone) supplemented with 10% FCS (HyClone), 2 mM L-glutamine (Invitrogen Life Technologies), 50 mM β-ME, 100 U/ml penicillin and 100 mg/ml streptomycin (Invitrogen Life Technologies). Cultures were incubated at 37 ºC in a 5% CO 2 atmosphere. After 48 h, non-adherent cells were removed by washing with 1 × PBS, and fresh medium was added. Medium was changed every 3-4 days. When the cells reached 80% confluence, the monolayer was washed twice with 1 × PBS, then lifted by incubation for 2-3 min at 37 ºC with a 0.25% trypsin solution containing 0.01% EDTA (Invitrogen Life Technologies). Trypsin was neutralized by the addition of fresh complete medium. The resulting suspension was then expanded by plating at 6 000-10 000 cells/cm 2 in 75-cm 2 dishes. Identical conditions were used for subsequent passages [31] .
Differentiation of murine MSCs
Before further expansion and experimental use, as an additional quality control, we tested MSCs cultures for their ability to undergo differentiation into chondrocytes, osteocytes and adipocytes. Cells were trypsinized, harvested and plated at 5 × 10 4 cells per well in 24-well plates in complete medium. Medium was replaced 24 h after plating. Chondrogenic differentiation was induced in some of the pelleted cells of the initial culture by ascorbic acid (50 mg/ml) and TGFβ-1 (1 ng/ml) in complete medium. After 2 weeks, plates were washed with 1 × PBS, fixed with 4% paraformaldehyde, and stained with 0.05% alcian blue. Osteogenic differentiation was induced in other cells of the initial culture by adding ascorbic acid (50 mg/ml), sodium β-glycerophosphate (10 mM) and dexamethasone (10 -8 
Flow cytometric analysis
Flow cytometric analysis was performed in PBS with 1% FBS with the following mAbs: R-phycoerythrin (PE)-conjugated antimouse CD45 (clone 30-F11, Biolegend), H-2K b (clone AF6-88.5, Biolegend), I-A b (clone AF6-120.1, Biolegend), CD25 (PE, clone PC61, eBioscience), B7-DC (PE, clone TY25, eBioscience), B7-H1 (PE, clone MIH5, eBioscience), B7-H3 (PE, clone M3.2D7, eBioscience), B7-H4 (PE, clone 188, eBioscience), c-kit (PE-Cy5, clone ack2, eBioscience), FLK-1 (PE, clone Avas12a1, eBioscience), SSEA-1 (FITC, Santa Cruz), sca-1 (PE, clone D7, eBioscience) and Thy1.1 (FITC, clone HIS51, eBioscience). Flow cytometry was performed using a FACS Calibur cytometer (BD Biosciences) and analyzed using Cellquest software and Modfit software (BD Biosciences). For intracellular staining, cells were fixed and permeabilized (BD cytofix/cytoperm TM , San Diego, CA) before incubation with PE-conjugated anti-IFNγ (BD Pharmingen), and Golgiplug (BD Biosciences, San Diego, CA) was added for the final 6 h before staining. Isotypic control analyses were performed in parallel.
Proliferation and blocking assays
In proliferation assays, mouse lymphocytes (1 × 10 5 per well) were cultured in triplicate in complete DMEM (DMEM with 10% fetal calf serum, HEPES, β-mercaptoethanol, L-glutamine, sodium pyruvate and penicillin/streptomycin) in 96-well flat-bottomed plates. Cells were cultured in the presence or absence of the pre-adherent MSCs and stimulated by mouse anti-CD3 (clone 145-2C11, eBioscience) and anti-CD28 (clone 37.51, eBioscience) (100 and 200 ng/ml, respectively) at 37 ºC in 5% CO 2 for 72 h. Cells were pulsed with 1 mCi [ 3 H]-thymidine (Shanghai Institute of Atomic Nucleus, Chinese Academy of Sciences) during the last 16-18 h of culture prior to harvest. [ 3 H]-thymidine incorporation was measured as cpm using a β-plate counter. IFNγ-/-knocknout mouse were provided by Dr Xiaodong Wu (Shanghai Institutes of Biological Sciences, Chinese Academy of Sciences, Shanghai, China), who did the same experiments as the protocol of wt mice. Percentage of inhibition on the proliferation of lymphocytes derived from IFNγ-/-knockout or wt mouse was calculated as [1-(CPM of stimulated lymphocytes co-cultured with MSCs/the sum of CPM of lymphocytes upon the stimuli of anti-CD3/anti-CD28 alone)] × 100%. In blocking assays, first collecting the supernatant of lymphocytes upon the stimuli of anti-CD3 and anti-CD28, then incubate it with anti-mouse IFNγ antibody (clone: R4-6A2, eBioscience) for 1 h prior to culturing the MSCs. After culturing for 24hr, MSCs are trypsinized and detected the B7-H1 expression profile by FACS.
Real-time PCR
Total RNA from MSCs or lymphocytes, the latter co-cultured with MSCs or activated by anti-CD3/CD28, was extracted using TRIzol reagent (Invitrogen Life Technologies), then reverse transcribed using a First Strand cDNA Synthesis kit (Fermentas Life Science); cDNA was analyzed by real-time PCR using SYBR Green Master Mix (Applied Biosystems). Thermocycler conditions comprised an initial holding at 50 ºC for 2 min and a subsequent holding at 95 ºC for 10 min, which was followed by a two-step PCR program at 95 ºC for 15 s and 60 ºC for 60 s for 40 cycles. In the end, a dissociation stage was added using 95 ºC for 15 s, 60 ºC for 15 s and 95 ºC for 15 s. For β-actin, B7-H1, IDO and PGE2, two sets of primers were used: β-actin amplicon forward, TGT CCA CCT TCC AGC AGA TGT, and reverse, AGC TCA GTA ACA GTC CGC CTA GA; B7-H1 amplicon forward, CTA CGG TGG TGC GGA CTA CA, and reverse, CAT GCT CAG AAG TGG CTG GAT; IDO forward, GCC CAC CGG AAC TTC CTT T, and reverse, CAC TCG TTA TAA GCT TTC GTC AAG TC; PGE2 forward, TGC CAT GTA CCT CAT CAG CAA, and reverse CGG CTG TCA CCC ACT TGT T. Data were collected and quantitatively analyzed on an ABI Prism 7900 Sequence Detection System [41] (Applied Biosystems).
siRNA oligo transfection and CFSE cell tracer-labeling
MSCs were precoated on 12-well plates (Costar, Corning Incorporated). The siRNA oligo and the GenePORTER reagent (Gene Therapy Systems) were diluted with serum-free medium, then mixed and incubated at room temperature for 20 min. Culture medium was aspirated from the cells, the mixture added to the cells and the culture incubated at 37 ºC for 3-5 h. Post-transfection, 1 volume of medium containing 20% FCS was added and the culture incubated overnight under 5-10% CO 2 at 37 ºC. At 24 h post-transfection, addition of cells or stimulation by IFNγ was undertaken. Carboxyfluorescein diacetate, succinimidyl ester (CFSE) labeling of lymphocytes was performed as described previously. Briefly, cells were extensively washed and resuspended at a final concentration of 3 × 10 6 cells/ml in 0.1% BSA PBS. CFSE was added at a final concentration of 5 mM and incubated for 10 min at room temperature. Staining was quenched by addition of 5 volumes of ice-cold culture medium. This was followed by washing with 10% heat-inactivated fetal calf serum-containing DMEM-LG. Cells then received the stimulus of anti-CD3/CD28 in the presence or absence of MSCs for 3-4 days.
Statistical analysis
Differences in cell surface molecular expression and cpm of proliferation tests were analyzed by the Mann-Whitney U test. A Student's t-test was used to analyze the differences between the groups. One-way ANOVA was initially performed to determine whether an overall statistically significant change existed before using the two-tailed paired or unpaired Student's t-test. A P-value of < 0.05 was considered statistically significant.
